Shandong Boan Biotechnology Co., Ltd. (HKG:6955)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
7.26
+0.19 (2.69%)
At close: Mar 6, 2026
Market Cap4.52B +2.1%
Revenue (ttm)829.27M +5.1%
Net Income35.10M -48.2%
EPS0.06 -53.6%
Shares Out622.33M
PE Ratio117.58
Forward PE24.61
Dividendn/a
Ex-Dividend Daten/a
Volume6,379,000
Average Volume2,935,620
Open7.15
Previous Close7.07
Day's Range7.05 - 7.43
52-Week Range6.78 - 25.00
Beta-0.46
RSI35.01
Earnings DateMar 26, 2026

About HKG:6955

Shandong Boan Biotechnology Co., Ltd., a biopharmaceutical company, develops, manufactures, and markets biologics in Mainland China. The company offers Boyounuo (BA1101), an anti-VEGF humanized monoclonal antibody injection for mCRC, advanced metastatic or recurrent non-small cell lung cancer, recurrent glioblastoma, epithelial ovarian, fallopian tube, primary peritoneal cancer, cervical cancer, and hepatocellular carcinoma indications; Boyoubei (BA6101), a human immunoglobulin G2 monoclonal antibody of the RANK ligand for the treatment of post... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2013
Employees 714
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 6955
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements